Peplin, Incorporation Earning & Dividend Analysis - PLI AUSTRALIA Market Size, Market Share and Demand Forecast

Wright Reports > Earnings Analysis Report > P > Peplin, Incorporation

Peplin, Incorporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Peplin, Incorporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Peplin, Incorporation. The Group's principal activities are developing and commercializing medical dermatology products for the treatment of cancers and other diseases . Its products include PEP005 Topical gel, which is used for treating Actinic keratosis (AK) and Basal cell carcinoma (BCC), PEP005 IV for Leukemia, PEP005 IC for Superficial bladder cancer and EPUFAs for general cancer and pain. It operates in Australia.

Not the Report you are looking for? Click here for more browsing options.

add Premium Analyses Reports:
Purchase Reports:			(Combined total)
ALL Basic Reports on this Company	$39.95	+ Analyses Reports	$64.95
Single Earnings Analysis Report	$24.95
or SUBSCRIBE for full access** to over 180,000 company reports:
Monthly Basic Subscription	$59.99	+ Analyses Reports	$89.99
Annual Basic Subscription	$600/yr	+ Analyses Reports	$750/yr

* If a currency is not selected, the report will be delivered in the local currency of the company
** Full access limits users to 500 reports per month

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report

HOME | ABOUT US | FEEDBACK | HELP | CONTENT MAP
Terms and Conditions